Literature DB >> 3335986

Clinical and laboratory correlates of esophagitis in young children.

J S Hyams1, A Ricci, A M Leichtner.   

Abstract

To develop clinical and laboratory criteria to identify young children with gastroesophageal reflux (GER) who are at particular risk for esophagitis and then to monitor their clinical course we have prospectively studied 40 subjects (ages 2-22 months, mean 8 months) with persistent symptoms of GER with 18 h intraesophageal pH monitoring, endoscopy, and grasp and suction esophageal biopsies. Esophagitis was found in 16 of 20 patients under 7 months, 12 of 14 between 7 and 12 months, and five of six between 12 and 24 months. Esophagitis was equally frequent in those patients with or without poor weight gain, wheezing, or irritability. Only 15% of patients with esophagitis had occult blood in their stool. No parameter of intraesophageal pH monitoring was both sensitive and specific in identifying patients who were ultimately found to have either mild or severe esophagitis. Follow-up data (37 patients) revealed that fundoplication was eventually required in four of eight patients with severe esophagitis, three of 22 with mild esophagitis, and none of seven without esophagitis. Currently used clinical and laboratory assessments of GER have limited value in identifying those children with either normal esophageal mucosa or at risk for varying degrees of esophagitis. Preliminary observations suggest that the presence of severe histologic esophagitis at the time of initial evaluation may have prognostic value in identifying those patients most likely to fail medical therapy and require fundoplication.

Entities:  

Mesh:

Year:  1988        PMID: 3335986     DOI: 10.1097/00005176-198801000-00011

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  12 in total

1.  Clinical and pH-metric characteristics of gastro-oesophageal reflux secondary to cows' milk protein allergy.

Authors:  F Cavataio; G Iacono; G Montalto; M Soresi; M Tumminello; A Carroccio
Journal:  Arch Dis Child       Date:  1996-07       Impact factor: 3.791

Review 2.  Current pharmacological management of gastro-esophageal reflux in children: an evidence-based systematic review.

Authors:  Mark P Tighe; Nadeem A Afzal; Amanda Bevan; R Mark Beattie
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

Review 3.  Proton pump inhibitors for eosinophilic oesophagitis.

Authors:  Edaire Cheng
Journal:  Curr Opin Gastroenterol       Date:  2013-07       Impact factor: 3.287

4.  Oesophageal pH monitoring and reflux oesophagitis in irritable infants.

Authors:  Yvan Vandenplas; Hegar Badriul; Marc Verghote; Bruno Hauser; Leonard Kaufman
Journal:  Eur J Pediatr       Date:  2004-06       Impact factor: 3.183

5.  Role of gastro-oesophageal reflux in infant irritability.

Authors:  R G Heine; A Jaquiery; L Lubitz; D J Cameron; A G Catto-Smith
Journal:  Arch Dis Child       Date:  1995-08       Impact factor: 3.791

6.  Intraepithelial cells with irregular nuclear contours as a marker of esophagitis in children with gastroesophageal reflux disease.

Authors:  S Cucchiara; F D'Armiento; E Alfieri; L Insabato; R Minella; T M De Magistris; A Scoppa
Journal:  Dig Dis Sci       Date:  1995-11       Impact factor: 3.199

7.  Diagnostic accuracy of pH monitoring in gastro-oesophageal reflux.

Authors:  L Da Dalt; S Mazzoleni; G Montini; F Donzelli; F Zacchello
Journal:  Arch Dis Child       Date:  1989-10       Impact factor: 3.791

8.  Effect of general anaesthesia on prolonged intraoesophageal pH monitoring.

Authors:  W A McCallion; T M Gallagher; V E Boston; S R Potts
Journal:  Arch Dis Child       Date:  1995-09       Impact factor: 3.791

9.  Endoluminal gastroplication in children with significant gastro-oesophageal reflux disease.

Authors:  M Thomson; A Fritscher-Ravens; S Hall; N Afzal; P Ashwood; C P Swain
Journal:  Gut       Date:  2004-12       Impact factor: 23.059

10.  Regurgitation in healthy and non healthy infants.

Authors:  Flavia Indrio; Giuseppe Riezzo; Francesco Raimondi; Luciano Cavallo; Ruggiero Francavilla
Journal:  Ital J Pediatr       Date:  2009-12-09       Impact factor: 2.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.